Introduction Colorectal cancer remains one of the leading causes of cancer-related deaths worldwide. For patients with advanced stages of the disease—particularly those who have exhausted first-line and second-line treatment options—new therapies offer a potential extension of life and symptom control. One such targeted therapy is Elunate, which contains the active pharmaceutical ingredient fruquintinib. What is […]
